Quality of Life

The following is a collection of research abstracts pertaining to the application of rTMS and other electromagnetic stimulation techniques for the relief of Parkinson's disease symptoms. There is also additional supporting evidence for the proposed potential of electromagnetic therapy application for relieving the symptoms of Parkinson's disease as well as support for the associated theory of mechanism of operation driving the change.

1. Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields.
   Int J Neurosci. 1995 Jun;82(3-4):269-83.
   Sandyk R.
   NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.

   Neuropsychological studies have demonstrated that Parkinson's disease (PD) is associated with various cognitive deficits ultimately leading in about 30% of patients to the development of dementia. These studies have demonstrated also a greater decrement of right hemispheric functions which are manifested by visuospatial deficits occurring in up to 90% of PD patients. The Human Figure Drawing Test has been employed in the assessment of generalized intellectual deterioration and specifically in the evaluation of visuoperceptive, visuospatial and visuoconstructional abilities in brain injured patients. I have demonstrated recently, on the basis of various drawing tests, that external application of electromagnetic fields (EMFs) in the picotesla (pT) range intensity improved visuoperceptive and visuospatial functions in Parkinsonian patients. In the present communication I present 4 fully medicated nondemented Parkinsonian patients who were administered the Human Figure Drawing Test before and after a series of treatments with EMFs. The Human Figure Drawing Test was selected for the study specifically since it was shown to be sensitive to the effects of surgery to the basal ganglia in Parkinsonian patients. Prior to application of EMFs these patients' drawings showed distortion, poor perspective, impoverished facial expression, and lack of attention to details suggested poor body image perception related to right posterior hemispheric dysfunction. In response to the administration of EMFs the group demonstrated a striking improvement in the drawings particularly the depiction of the face the perception of which is localized to the right parietal lobe. These findings demonstrate that treatment with pT EMFs improves body image perception in Parkinsonian patients, a deficit which may remain unaffected by treatment with standard dopaminergic pharmacotherapy.

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

Copyright © 2009 by Pico-Tesla. All rights reserved
Sitemap | Privacy Policy & Terms of Use

Website design by DDA Medical

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical^®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.

About Us | Our Team | Participate In Our Research | News Releases | Terms & Conditions of Use
Patients & Caregivers | Physicians & Medical Providers | Research & Publications | Press Kit & News | FDA Approval Status
The Device Overview | The Device | User Interface | Safety and Risks | FDA Clearance
Neuromodulation & Electromagnetics Overview | The Resonator™ Device Compared to MRI | The Resonator™ Device Versus TMS and rTMS
The Resonator™ Device Compared to Other Parkinson's Disease Therapies | Theory of Mechanism Overview | Jacobson Resonance™
Parkinson's Disease Study | Alzheimer's Disease Study | Fibromyalgia Disease Study | Osteoarthritis Disease Study
Pico-Tesla’s Resonator™ Magnetic Therapy Device | Resonator™ Magnetic Therapy Device | A Complementary and Alternative Medicine
Complementary and Alternative Therapy | Magnetic Resonance Therapy | Conditions Treated with Magnetic Therapy
Other Forms of Deep Brain Stimulation

For patients living with Parkinson’s disease in the Tampa Bay area, Pico-Tesla Magnetic Therapies is running clinical trials to demonstrate the efficacy of the Resonator® device, which uses pulsed magnetic field therapy in treating patients with Parkinson’s disease. Subjects of the trial will be treated with the magnetic therapy device three times per week for 8 weeks with each session lasting about 1.5 hours. This new magnetic therapy focuses on improving the quality of life for people living with Parkinson’s disease by using a non-invasive approach.

Patients living in central west Florida should contact Pico-Tesla at 727-474-3722 for more information. These clinical trials will be held in the city of Clearwater, FL, located west of Tampa, and serving the counties of Pinellas, Hillsborough, Pasco and Manatee in Florida.